IOL CHEMICALS & PHARM. | SAKAR HEALTHCARE | IOL CHEMICALS & PHARM./ SAKAR HEALTHCARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.3 | 63.0 | 21.1% | View Chart |
P/BV | x | 1.5 | 4.5 | 33.4% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. SAKAR HEALTHCARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SAKAR HEALTHCARE Mar-23 |
IOL CHEMICALS & PHARM./ SAKAR HEALTHCARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 295 | 181.9% | |
Low | Rs | 272 | 112 | 243.5% | |
Sales per share (Unadj.) | Rs | 377.6 | 70.0 | 539.2% | |
Earnings per share (Unadj.) | Rs | 23.7 | 6.7 | 353.7% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 14.6 | 216.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 91.0 | 282.1% | |
Shares outstanding (eoy) | m | 58.71 | 19.04 | 308.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.9 | 36.9% | |
Avg P/E ratio | x | 17.1 | 30.4 | 56.2% | |
P/CF ratio (eoy) | x | 12.8 | 14.0 | 91.8% | |
Price / Book Value ratio | x | 1.6 | 2.2 | 70.5% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 3,873 | 613.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 158 | 1,064.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 1,334 | 1,662.5% | |
Other income | Rs m | 256 | 47 | 547.8% | |
Total revenues | Rs m | 22,427 | 1,380 | 1,624.8% | |
Gross profit | Rs m | 2,257 | 333 | 678.4% | |
Depreciation | Rs m | 462 | 150 | 308.0% | |
Interest | Rs m | 165 | 60 | 276.2% | |
Profit before tax | Rs m | 1,887 | 170 | 1,110.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 42 | 1,169.6% | |
Profit after tax | Rs m | 1,391 | 128 | 1,090.5% | |
Gross profit margin | % | 10.2 | 24.9 | 40.8% | |
Effective tax rate | % | 26.2 | 24.9 | 105.4% | |
Net profit margin | % | 6.3 | 9.6 | 65.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 559 | 1,728.8% | |
Current liabilities | Rs m | 5,025 | 545 | 922.2% | |
Net working cap to sales | % | 20.9 | 1.1 | 1,960.6% | |
Current ratio | x | 1.9 | 1.0 | 187.5% | |
Inventory Days | Days | 43 | 29 | 147.0% | |
Debtors Days | Days | 8 | 604 | 1.4% | |
Net fixed assets | Rs m | 11,017 | 2,804 | 392.9% | |
Share capital | Rs m | 587 | 190 | 308.4% | |
"Free" reserves | Rs m | 14,490 | 1,543 | 939.0% | |
Net worth | Rs m | 15,077 | 1,733 | 869.8% | |
Long term debt | Rs m | 0 | 982 | 0.0% | |
Total assets | Rs m | 20,684 | 3,363 | 615.0% | |
Interest coverage | x | 12.5 | 3.8 | 323.5% | |
Debt to equity ratio | x | 0 | 0.6 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.4 | 270.3% | |
Return on assets | % | 7.5 | 5.6 | 135.2% | |
Return on equity | % | 9.2 | 7.4 | 125.4% | |
Return on capital | % | 13.6 | 8.5 | 161.0% | |
Exports to sales | % | 26.7 | 78.4 | 34.1% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 1,045 | 567.3% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 1,045 | 567.3% | |
Fx outflow | Rs m | 6,052 | 355 | 1,703.0% | |
Net fx | Rs m | -122 | 690 | -17.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 333 | 366.7% | |
From Investments | Rs m | -1,200 | -744 | 161.3% | |
From Financial Activity | Rs m | -41 | 411 | -10.0% | |
Net Cashflow | Rs m | -18 | 1 | -2,875.0% |
Indian Promoters | % | 48.2 | 53.2 | 90.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 24.4 | 7.0% | |
FIIs | % | 1.4 | 13.8 | 10.2% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 46.9 | 110.6% | |
Shareholders | 130,003 | 7,001 | 1,856.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | SAKAR HEALTHCARE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.54% | -2.97% | -1.23% |
1-Month | 7.66% | -0.84% | 1.07% |
1-Year | -1.73% | 62.56% | 50.86% |
3-Year CAGR | -11.66% | 50.84% | 14.38% |
5-Year CAGR | 15.36% | 38.92% | 19.01% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the SAKAR HEALTHCARE share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of SAKAR HEALTHCARE the stake stands at 53.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of SAKAR HEALTHCARE .
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
SAKAR HEALTHCARE paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of SAKAR HEALTHCARE .
For a sector overview, read our pharmaceuticals sector report.
It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.